Skip to main content

Series C+ · 2026-11-17 · Healthcare

Isomorphic Labs raises $5.00B

88
AI Score
Amount
$5.00B
Round
Series C+
Lead
Greenoaks, Sequoia
HQ
GB
Why it matters: The round comes six months after a $2.1bn Series B, showing how much capital investors are willing to put behind AI-driven drug discovery before any candidate reaches clinical trials.

Isomorphic Labs, the London drug discovery company spun out of Google DeepMind, raised a $5bn Series C co-led by Sequoia and Greenoaks.

Participants:
Andreessen Horowitz, Thrive Capital, Alphabet, GV, CapitalG, Tamesek, Sovereign AI fund

Deal Dossier PRO

Pro feature
Deal Dossier for Isomorphic Labs

Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.

Generate dossier — Pro
Already Pro? Sign in · See plans

Figures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).

More deals with Greenoaks

Recent Healthcare rounds

Browse all deals in the funding database →

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing